China Health Technology Group Holding Company Limited (HKG:1069)
0.2800
-0.0100 (-3.45%)
May 29, 2026, 3:18 PM HKT
HKG:1069 Income Statement
Financials in millions CNY. Fiscal year is July - June.
Millions CNY. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 93.5 | 90.22 | 47.61 | 58.72 | 6.76 | - | |
Revenue Growth (YoY) | 56.62% | 89.50% | -18.92% | 769.11% | - | - |
Cost of Revenue | 83.92 | 82 | 45.71 | 47.21 | 6.76 | - |
Gross Profit | 9.57 | 8.21 | 1.9 | 11.51 | - | - |
Selling, General & Admin | 15.97 | 16.54 | 22.89 | 19.92 | 11.71 | 21.44 |
Operating Expenses | 15.97 | 16.54 | 22.89 | 19.92 | 11.71 | 21.44 |
Operating Income | -6.4 | -8.33 | -21 | -8.41 | -11.71 | -21.44 |
Interest Expense | -3.96 | -3.5 | -3.23 | -11.68 | -21.22 | -22.52 |
Interest & Investment Income | 0 | 0 | 0 | 0.01 | 0 | 2.4 |
Currency Exchange Gain (Loss) | 1.84 | - | - | -34.57 | - | -0 |
Other Non Operating Income (Expenses) | 0.22 | -0.15 | -3.19 | 0.08 | 0.15 | 0.09 |
EBT Excluding Unusual Items | -8.29 | -11.98 | -27.41 | -54.57 | -32.78 | -41.48 |
Gain (Loss) on Sale of Assets | - | - | -0.3 | -0.08 | -0.13 | 0.04 |
Asset Writedown | 31.53 | 35.01 | 25.7 | 38.11 | 12.53 | -322.91 |
Other Unusual Items | - | - | 202.02 | 7.16 | - | - |
Pretax Income | 23.24 | 23.03 | 200.02 | -9.37 | -20.38 | -364.34 |
Income Tax Expense | 0.26 | 0.32 | 0.01 | 1.43 | - | - |
Earnings From Continuing Operations | 22.99 | 22.71 | 200.01 | -10.8 | -20.38 | -364.34 |
Earnings From Discontinued Operations | - | - | - | - | 1.48 | -4.74 |
Net Income to Company | 22.99 | 22.71 | 200.01 | -10.8 | -18.9 | -369.09 |
Net Income | 22.99 | 22.71 | 200.01 | -10.8 | -18.9 | -369.09 |
Net Income to Common | 22.99 | 22.71 | 200.01 | -10.8 | -18.9 | -369.09 |
Net Income Growth | 543.84% | -88.64% | - | - | - | - |
Shares Outstanding (Basic) | 93 | 83 | 67 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 93 | 83 | 67 | 11 | 11 | 11 |
Shares Change (YoY) | 23.53% | 22.96% | 509.04% | - | - | - |
EPS (Basic) | 0.25 | 0.28 | 2.98 | -0.98 | -1.71 | -33.48 |
EPS (Diluted) | 0.25 | 0.28 | 2.98 | -0.98 | -1.71 | -33.48 |
EPS Growth | 421.19% | -90.77% | - | - | - | - |
Free Cash Flow | 13.87 | -0.89 | 2.37 | 0.16 | -0.47 | 0.11 |
Free Cash Flow Per Share | 0.15 | -0.01 | 0.04 | 0.01 | -0.04 | 0.01 |
Gross Margin | 10.24% | 9.10% | 3.98% | 19.60% | - | - |
Operating Margin | -6.84% | -9.23% | -44.10% | -14.32% | -173.28% | - |
Profit Margin | 24.58% | 25.17% | 420.14% | -18.39% | -279.75% | - |
Free Cash Flow Margin | 14.84% | -0.99% | 4.97% | 0.28% | -6.90% | - |
EBITDA | -5.94 | -8.07 | -20.74 | -8.4 | -11.7 | -21.38 |
EBITDA Margin | -6.35% | -8.95% | -43.56% | -14.30% | -173.10% | - |
D&A For EBITDA | 0.46 | 0.26 | 0.26 | 0.01 | 0.01 | 0.06 |
EBIT | -6.4 | -8.33 | -21 | -8.41 | -11.71 | -21.44 |
EBIT Margin | -6.84% | -9.23% | -44.10% | -14.32% | -173.28% | - |
Effective Tax Rate | 1.10% | 1.37% | 0.00% | - | - | - |